Application due dates on or after September 25, 2022 and subsequent receipt dates through January 7, 2025.
The purpose of this NOSI is to encourage research grant applications focused on respiratory complications of the muscular dystrophies. This includes further elucidation of respiratory phenotypes in humans; research to optimize pulmonary function testing and existing respiratory therapies in humans; and mechanistic and translational research, including in vitro and in animal models, that examines respiratory muscle response to gene therapies and other therapeutic strategies in the muscular dystrophies.
Topics: Clinical Presentation of Infection, ARDS, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COPD, COVID-19, Neurological Disorders, Community Engagement, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Health Disparities, Healthcare Implementation, Research Model Development, Research Models, Mouse Models, Research Site, Community-based, Social Determinants of Health